ID

36268

Descrição

Phase I, Dose Escalation Study of Decitabine; ODM derived from: https://clinicaltrials.gov/show/NCT02264873

Link

https://clinicaltrials.gov/show/NCT02264873

Palavras-chave

Versões (1)
  1. 27/04/2019 27/04/2019 -
Titular dos direitos

See clinicaltrials.gov

Transferido a

27 de abril de 2019

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Leukemia, Lymphoblastic, Acute NCT02264873

Inglês

Eligibility Leukemia, Lymphoblastic, Acute NCT02264873

1 Formulários  
Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
age: greater than 1 and less than 31 years of age;
Descrição

Age

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0001779
diagnosis: history of all, aml or mds, currently in a complete remission (cr) following allo-hsct (bone marrow leukemic blasts less than 5% by morphology), with high risk features including:
Descrição

Acute lymphocytic leukemia | Leukemia, Myelocytic, Acute | MYELODYSPLASTIC SYNDROME | In complete remission Following Allogeneic Hematopoietic Stem Cell Transplantation | Bone Marrow Leukemic Blast Count | Feature High risk

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0023449
UMLS CUI [2]
C0023467
UMLS CUI [3]
C3463824
UMLS CUI [4,1]
C0677874
UMLS CUI [4,2]
C0332282
UMLS CUI [4,3]
C1705576
UMLS CUI [5,1]
C0005953
UMLS CUI [5,2]
C2697913
UMLS CUI [6,1]
C2348519
UMLS CUI [6,2]
C4319571
status post allogeneic hsct
Descrição

Status post Allogeneic Hematopoietic Stem Cell Transplantation

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0231290
UMLS CUI [1,2]
C1705576
gvhd prophylaxis:
Descrição

Prophylaxis against graft versus host disease

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1096407
karnofsky or lansky performance scores more than 50%. karnofsky scores will be used for patients > 16 years of age and lansky scores for patients ≤ 16 years of age;
Descrição

Karnofsky Performance Status | Lansky Play-Performance Status | Age

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0206065
UMLS CUI [2]
C1522275
UMLS CUI [3]
C0001779
platelet count ≥ 50,000 (untransfused);
Descrição

Platelet Count measurement | Transfusion Absent

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0032181
UMLS CUI [2,1]
C1879316
UMLS CUI [2,2]
C0332197
absolute neutrophil count ≥ 1000; and;
Descrição

Absolute neutrophil count

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0948762
hemoglobin ≥ 8 g/dl (un-transfused);
Descrição

Hemoglobin measurement | Transfusion Absent

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0518015
UMLS CUI [2,1]
C1879316
UMLS CUI [2,2]
C0332197
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
progressive disease;
Descrição

Progressive Disease

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1335499
philadelphia chromosome positive all (these patients receive tyrosine kinase inhibitor posttransplant);
Descrição

Philadelphia positive acute lymphocytic leukaemia | Tyrosine kinase inhibitor therapy Post Transplantation

Tipo de dados

boolean

Alias
UMLS CUI [1]
C4524071
UMLS CUI [2,1]
C0879484
UMLS CUI [2,2]
C0687676
UMLS CUI [2,3]
C0040732
known hypersensitivity to any components of decitabine;
Descrição

Hypersensitivity Decitabine Component

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0049065
UMLS CUI [1,3]
C1705248
uncontrolled grade 3-4 graft versus host disease;
Descrição

Graft-vs-Host Disease Grade Uncontrolled

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0018133
UMLS CUI [1,2]
C0441800
UMLS CUI [1,3]
C0205318
uncontrolled infection;
Descrição

Communicable Disease Uncontrolled

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C0205318
serum creatinine > 2 mg/dl or glomerular filtration rate (gfr) less than 60 ml/min/1.73m2 ;
Descrição

Creatinine measurement, serum | Glomerular Filtration Rate

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0201976
UMLS CUI [2]
C0017654
alanine aminotransferase (alt) greater than 3 times normal or serum total bilirubin greater than 2 mg/dl;
Descrição

Alanine aminotransferase increased | Serum total bilirubin measurement

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0151905
UMLS CUI [2]
C1278039
Voltar ao início da página

Similar models

Eligibility Leukemia, Lymphoblastic, Acute NCT02264873

1 Formulários
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age: greater than 1 and less than 31 years of age;
boolean
C0001779 (UMLS CUI [1])
Acute lymphocytic leukemia | Leukemia, Myelocytic, Acute | MYELODYSPLASTIC SYNDROME | In complete remission Following Allogeneic Hematopoietic Stem Cell Transplantation | Bone Marrow Leukemic Blast Count | Feature High risk
Item
diagnosis: history of all, aml or mds, currently in a complete remission (cr) following allo-hsct (bone marrow leukemic blasts less than 5% by morphology), with high risk features including:
boolean
C0023449 (UMLS CUI [1])
C0023467 (UMLS CUI [2])
C3463824 (UMLS CUI [3])
C0677874 (UMLS CUI [4,1])
C0332282 (UMLS CUI [4,2])
C1705576 (UMLS CUI [4,3])
C0005953 (UMLS CUI [5,1])
C2697913 (UMLS CUI [5,2])
C2348519 (UMLS CUI [6,1])
C4319571 (UMLS CUI [6,2])
Status post Allogeneic Hematopoietic Stem Cell Transplantation
Item
status post allogeneic hsct
boolean
C0231290 (UMLS CUI [1,1])
C1705576 (UMLS CUI [1,2])
Prophylaxis against graft versus host disease
Item
gvhd prophylaxis:
boolean
C1096407 (UMLS CUI [1])
Karnofsky Performance Status | Lansky Play-Performance Status | Age
Item
karnofsky or lansky performance scores more than 50%. karnofsky scores will be used for patients > 16 years of age and lansky scores for patients ≤ 16 years of age;
boolean
C0206065 (UMLS CUI [1])
C1522275 (UMLS CUI [2])
C0001779 (UMLS CUI [3])
Platelet Count measurement | Transfusion Absent
Item
platelet count ≥ 50,000 (untransfused);
boolean
C0032181 (UMLS CUI [1])
C1879316 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Absolute neutrophil count
Item
absolute neutrophil count ≥ 1000; and;
boolean
C0948762 (UMLS CUI [1])
Hemoglobin measurement | Transfusion Absent
Item
hemoglobin ≥ 8 g/dl (un-transfused);
boolean
C0518015 (UMLS CUI [1])
C1879316 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Progressive Disease
Item
progressive disease;
boolean
C1335499 (UMLS CUI [1])
Philadelphia positive acute lymphocytic leukaemia | Tyrosine kinase inhibitor therapy Post Transplantation
Item
philadelphia chromosome positive all (these patients receive tyrosine kinase inhibitor posttransplant);
boolean
C4524071 (UMLS CUI [1])
C0879484 (UMLS CUI [2,1])
C0687676 (UMLS CUI [2,2])
C0040732 (UMLS CUI [2,3])
Hypersensitivity Decitabine Component
Item
known hypersensitivity to any components of decitabine;
boolean
C0020517 (UMLS CUI [1,1])
C0049065 (UMLS CUI [1,2])
C1705248 (UMLS CUI [1,3])
Graft-vs-Host Disease Grade Uncontrolled
Item
uncontrolled grade 3-4 graft versus host disease;
boolean
C0018133 (UMLS CUI [1,1])
C0441800 (UMLS CUI [1,2])
C0205318 (UMLS CUI [1,3])
Communicable Disease Uncontrolled
Item
uncontrolled infection;
boolean
C0009450 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
Creatinine measurement, serum | Glomerular Filtration Rate
Item
serum creatinine > 2 mg/dl or glomerular filtration rate (gfr) less than 60 ml/min/1.73m2 ;
boolean
C0201976 (UMLS CUI [1])
C0017654 (UMLS CUI [2])
Alanine aminotransferase increased | Serum total bilirubin measurement
Item
alanine aminotransferase (alt) greater than 3 times normal or serum total bilirubin greater than 2 mg/dl;
boolean
C0151905 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial